These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2591574)

  • 1. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres: phase II clinical study.
    Singh M; Saxena BB; Graver R; Ledger WJ
    Fertil Steril; 1989 Dec; 52(6):973-80. PubMed ID: 2591574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norethisterone contraceptive microspheres.
    Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
    J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of injectable biodegradable contraceptive system.
    Beck LR; Ramos RA; Flowers CE; Lopez GZ; Lewis DH; Cowsar DR
    Am J Obstet Gynecol; 1981 Aug; 140(7):799-806. PubMed ID: 7020421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(DL-lactide-co-glycolide)/norethisterone microcapsules: an injectable biodegradable contraceptive.
    Beck LR; Pope VZ; Flowers CE; Cowsar DR; Tice TR; Lewis DH; Dunn RL; Moore AB; Gilley RM
    Biol Reprod; 1983 Feb; 28(1):186-95. PubMed ID: 6830939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study.
    Grubb GS; Welch JD; Cole L; Goldsmith A; Rivera R
    Fertil Steril; 1989 May; 51(5):803-10. PubMed ID: 2523322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of an improved injectable microcapsule contraceptive system.
    Beck LR; Flowers CE; Pope VZ; Wilborn WH; Tice TR
    Am J Obstet Gynecol; 1983 Dec; 147(7):815-21. PubMed ID: 6650605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New long-acting injectable microcapsule contraceptive system.
    Beck LR; Cowsar DR; Lewis DH; Gibson JW; Flowers CE
    Am J Obstet Gynecol; 1979 Oct; 135(3):419-26. PubMed ID: 114054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postovulatory contraception in women with large doses of norethindrone.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1972 Jun; 5(6):445-56. PubMed ID: 4650660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
    McEwan JA; Griffin M
    Contraception; 1991 Dec; 44(6):639-48. PubMed ID: 1773620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive efficacy of norethindrone encapsulated in injectable biodegradable poly-dl-lactide-co-glycolide microspheres (NET-90): phase III clinical study.
    Singh M; Saxena BB; Singh R; Kaplan J; Ledger WJ
    Adv Contracept; 1997 Mar; 13(1):1-11. PubMed ID: 9181181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
    Gulati K; Mapa MK; Gupta AN; Singh PM; Devi PK
    Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):281-6. PubMed ID: 6525083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.
    Singh M; Saxena BB; Raghubanshi RS; Ledger WJ; Harman SM; Leonard RJ
    Contraception; 1997 Jan; 55(1):23-33. PubMed ID: 9013058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.